RECOMBINANT HUMAN INTERLEUKIN-6 (IL-6) IS TOLERATED AT 25-PERCENT THEADULT MAXIMUM TOLERATED DOSE (MTD) BUT APPEARS TO ENHANCE HEMATOPOIETIC RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN CHILDREN - CORRELATION WITH INDUCTION OF INFLAMMATORY CYTOKINES AND MOBILIZATION OF EARLY PROGENITOR-CELL SUBSETS
F. Bracho et al., RECOMBINANT HUMAN INTERLEUKIN-6 (IL-6) IS TOLERATED AT 25-PERCENT THEADULT MAXIMUM TOLERATED DOSE (MTD) BUT APPEARS TO ENHANCE HEMATOPOIETIC RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN CHILDREN - CORRELATION WITH INDUCTION OF INFLAMMATORY CYTOKINES AND MOBILIZATION OF EARLY PROGENITOR-CELL SUBSETS, Blood, 90(10), 1997, pp. 3545-3545